The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery

Heart and Vessels

Volumn 24, Issue 3, 2009, Pages 169-174

  Matsuura, Kaoru ^a   Imamaki, Mizuho ^a   Ishida, Atsushi ^a   Shimura, Hitoshi ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Coronary artery bypass grafting; Endothelium; Off pump; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN III; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATINE KINASE MB; D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; OFF PUMP CORONARY SURGERY; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOCYTE COUNT; TURBIDIMETRY;

AGED; ASPIRIN; CORONARY ARTERY BYPASS, OFF-PUMP; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 66149115223     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1105-2     Document Type: Article

References (27)

1. Calafiore AM, Di Mauro M, Contini M, Di Giammarco G, Pano M, Vitolla G, Bivona A, Carella R, D'Alessandro S (2001) Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: Impact of the strategy on early outcome. Ann Thorac Surg 72:456-462
2. Kobayashi J, Sasako Y, Bando K, Niwaya K, Tagusari O, Nakajima H, Nakamura Y, Ishida M, Kitamura S (2002) Multiple off-pump coronary revascularization with "aorta no-touch" technique using composite and sequential methods. Heart Surg Forum 5:114-118
3. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, Staples JR, Glas KE, Marshall JJ, Leimbach ME, McCall SA, Petersen RJ, Bailey DE, Weintraub WS, Guyton RA (2004) Off pump vs conventional coronary artery bypass grafting: Early and 1-year graft patency, cost, and quality-of-life outcomes: A randomized trial. JAMA 291:1841-1849
4. Kihara S, Shimakura T, Tanaka SA, Hanayama N, Saito N, Sugawara Y, Hirasawa Y, Maeba S (2001) Initial experience with off-pump coronary artery bypass grafting. Heart Vessels 16:9-11
5. Kobayashi J, Tashiro T, Ochi M, Yaku H, Watanabe G, Satoh T, Tagusari O, Nakajima H, Kitamura S (2005) Japanese Off-Pump Coronary Revascularization Investigation (JOCRI) Study Group. Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation 112(9 suppl):338-343 338-343
6. Wan IY, Arifi AA, Wan S, Yip JH, Sihoe AD, Thung KH, Wong EM, Yim AP (2004) Beating heart revascularization with or without cardiopulmonary bypass: Evaluation of inflammatory response in a prospective randomized study. J Thorac Cardiovasc Surg 127:1624-1631
7. Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C, Wright RS (2005) Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 112(suppl 1):286-292
8. Williams MS, Kickler TS, Vaidya D, Ng'alla LS, Bush DE (2006) Evaluation of platelet function in aspirin treated patients with CAD. J Thromb Thrombolysis 21:241-247
9. Bhatt DL, Aranki S, Byrne J, Bhatia D, Mehta S, Mills R (2005) Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion. J Invasive Cardiol 17:283-287
10. Oberle S, Polte T, Abate A, Podhaisky HP, Schroder H (1998) Aspirin increases ferritin synthesis in endothelial cells. A novel antioxidant pathway. Circ Res 82:1016-1020
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979
12. Pernerstorfer T, Eichler HG, Stohlawetz P, Speiser W, Jilma B (2001) Effects of heparin and aspirin on circulation P-selectin, E-selectin and von Willebrand factor levels in healthy men. Atherosclerosis 155:389-393
13. Lopez-Farre A, Caramelo C, Esteban A, Alberola ML, MIllas I, Monton M, Casado S (1995) Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 91:2080-2088
14. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P (1999) Increased proinflammatory. Cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100:793-798
15. Stein B. Fuster V, Israel DH, Cohen M, Badimon K, Badimon JJ, Chesebro JH (1989) Platelet inhibitor agents in cardiovascular disease: An update. J Am Coll Cardiol 14:813-836
16. Bec L, Karolczak MA, Motylewicz B, Rogala E (2006) Is hypothermia a benefit? Von Willebrand factor in pediatric cardiopulmonary bypass. J Cardiovasc Surg 47:211-215
17. Holdright DR, Hunt BJ, Parratt R, Segal H, Clarke D, Taggart D, Bennett G, Collins P (1995) The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor. Eur J Cardiothorac Surg 9:18-21
18. Chong AY, Lip GYH, Freestone B, Blann AD (2006) Increased circulation endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E-selectin. Eur J Heart Failure 8:167-172
19. Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GYH (2006) Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol 97:671-675
20. Conway DSG, Pearse LA, Chin BSP, Hart RG, Lip GYH (2003) Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with non valvular atrial fibrillation. Circulation 107:3141-3145
21. Margulis T, David M, Soff GA, Grenadier E, Palant A, Agha E (1986) The von Willebrand factor in myocardial infarction and unstable angina: A kinetic study. Thromb Haemostas 55:366-368
22. Jansson JH, Nilsson TK, Johnson O (1991) Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death. Br Heart J 66:351-355
23. Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GYH (2004) Endothelial dysfunction and damage in congestive heart failure. Relation of flow-mediated dilation to circulation endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 110:1794-1798
24. Chen MC, Chen CJ, Yang CH, Liu WH, Fang CY, Hsieh YK, Chang HW (2008) Relationship of the percentage of circulating endothelial progenitor cell to the severity of coronary artery disease. Heart Vessels 23:47-52
25. Lip GYH, Gibbs CR (1999) Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 33:1424-1426
26. Srinivasan AK, Grayson AD, Pullan DM, Fabri BM, Dihmis WC (2003) Effect of preoperative aspirin use in off-pump coronary artery bypass operations. Ann Thorac Surg 76:41-45
27. D'Ancona G, Donias HW, Karamanoukian RL, Bergsland J, Karamanoukian HL (2001) OPCAB therapy survey: Off-pump clopidogrel, aspirin or both therapy survey. Heart Surg Forum 4:354-358